Development and External Validation of a Machine Learning-Based Risk Classification Score for Prostate Cancer-Specific Cardiovascular Risk
JCO Oncol Pract. 2026 May 29:OP2600131. doi: 10.1200/OP-26-00131. Online ahead of print.ABSTRACTPURPOSE: Patients with prostate cancer (PC) face elevated cardiovascular (CV) risk. Conventional CV risk scores are often poorly calibrated for PC and require laboratory tests that are not routinely avail

